Revance Therapeutics Inc (RVNC)

3.08 +0.01 (+0.33%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Revance Therapeutics EPS Estimates for Next Fiscal Year

EPS Estimates for Next Fiscal Year Chart

View EPS Estimates for Next Fiscal Year for RVNC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Earnings Per Share Estimates Definition

View Earnings Per Share Estimates Definition
Start Trial

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Fiscal Year Range, Past 5 Years

View EPS Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Fiscal Year Benchmarks

View EPS Estimates for Next Fiscal Year Benchmarks
Start Trial
Recursion Pharmaceuticals Inc Upgrade
Regeneron Pharmaceuticals Inc Upgrade
Ligand Pharmaceuticals Inc Upgrade
MEI Pharma Inc Upgrade
Cellectar Biosciences Inc Upgrade

EPS Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade